Evidence map›Paper›PMID 42427272›Full record

ArticleACR open rheumatology2026

Cutaneous IgA Vasculitis in Primary Sjögren Disease: Findings From a Medical Record-Based Review.

Shay Brikman, Mohammad Egbaria, Amir Bieber

Abstract read
In one paragraph

Article in ACR open rheumatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Shay BrikmanThe Ruth and Bruce Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel.
Mohammad EgbariaThe Ruth and Bruce Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel.
Amir BieberThe Ruth and Bruce Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel.ORCID https://orcid.org/0000-0002-0395-4171

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThis study aimed to describe clinical observations of patients presenting with palpable purpura, which is suspected to represent IgA vasculitis (IgAV) based on direct immunofluorescence (DIF), who were ultimately diagnosed with cutaneous vasculitis associated with primary Sjögren disease (SjD).

methodsWe retrospectively reviewed biopsy reports from a single center between 2014 and 2022 consistent with IgAV, identifying patients who were concurrently diagnosed with SjD. Data collected included clinical history, serologic findings, and skin biopsy results with DIF. A focused literature review was also performed to assess prior reports and to explore potential underlying mechanisms.

resultsWe reviewed 103 biopsy reports from a single center between 2014 and 2022 that were consistent with IgAV. Three female patients with SjD who developed palpable purpura, initially suspected to represent IgAV, were identified. This corresponds to a prevalence of 2.91% (95% confidence interval 0.61%-8.28%). All patients were seropositive for antinuclear antibodies and anti-SSA antibodies. In two of the three cases, cutaneous vasculitis was the first manifestation of SjD. In all patients, skin biopsy demonstrated small-vessel leukocytoclastic vasculitis, and DIF revealed perivascular IgA and C3 deposits without IgG deposits. The diagnosis was revised to cutaneous vasculitis associated with SjD following comprehensive clinical evaluation.

conclusionThis case series suggests that IgAV may overlap with SjD. Clinicians should consider underlying SjD in patients presenting with features of IgAV, and histopathologic findings alone should not exclude the possibility of an underlying systemic autoimmune disease.

Identifiers

PMID42427272
PMCPMC13351931

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.